There is no doubt that the accomplishments of the past 15 years are remarkable and worth discussion.

At Johns Hopkins, researchers and clinicians believe thatcancer stem cells may be a new therapeutic target for cancer.

In the case of tonsillar cancers, a type of cancer that has been steadily on the rise since 1973, the link to HPV may be a good thing.

Reflections on the decade and a half at the helm of one of the world's greatest cancer centers and the years leading up to it.

The years 2002-2007 see continued momentum and powerful growth for the Kimmel Cancer Center.

Big describes the type of changes that marked the years 1997-2001.

Led by new genetic discoveries and other pioneering cancer research, 1992-1996 were marked by tremendous growth.

The Martin D. Abeloff Scholars Program will help change, forever, how cancer is managed.

A research team at the Johns Hopkins Kimmel Cancer Center is one of six in the nation to share in a $120 million gift from the Ludwig Fund.

The Johns Hopkins University is one of the top FAMRIfunded institutions.

Thirty years ago, when the first facility to house a cancer center at Johns Hopkins (then called the Oncology Center) was being built, the Center’s director, Albert H. Owens, had a vision.

Very few people have done more to reach out to neighbors and advance our healing sciences than Dr. Martin Abeloff.

Isn’t it remarkable that a doctor as busy as Marty would be so prescient as to recognize the importance of art as an essential component of his wonderful new building?    

Johns Hopkins is #1, in my opinion, in the country. Martin Abeloff has played a key role in making it the best.

During Marty’s time as director, our Cancer Center has grown in national prominence to be one of a small group of very visible centers of excellence in oncology in the country.